Prediction of Left Ventricular Mass Index Using Electrocardiography in Essential Hypertension - A Multiple Linear Regression Model

被引:1
|
作者
Ahmed, Shah Newaz [1 ]
Jhaj, Ratinder [1 ]
Sadasivam, Balakrishnan [1 ]
Joshi, Rajnish [2 ]
机构
[1] All India Inst Med Sci Bhopal, Dept Pharmacol, Bhopal, Madhya Pradesh, India
[2] All India Inst Med Sci Bhopal, Dept Gen Med, Bhopal, Madhya Pradesh, India
关键词
left ventricular hypertrophy; electrocardiography; echocardiography; BLOOD-PRESSURE; HYPERTROPHY; ECHOCARDIOGRAPHY; RECOMMENDATIONS; REAPPRAISAL; ASSOCIATION; DIAGNOSIS; CRITERIA; SOCIETY;
D O I
10.2147/MDER.S253792
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Background: Current electrocardiography (ECG) criteria indicate only the presence or absence of left ventricular hypertrophy (LVH). LVH is a continuum and a direct relationship exists between left ventricular mass (LVM) and cardiovascular event rate. We developed a mathematical model predictive of LVM index (LVMI) using ECG and non-ECG variables by correlating them with echocardiography determined LVMI. Patients and Methods: The model was developed in a cohort of patients on treatment for essential hypertension (BP>140/90 mm of Hg) who underwent concurrent ECG and echocardiography. One hundred and forty-seven subjects were included in the study (56.38 +/- 11.84 years, 66% males). LVMI was determined by echocardiography (113.76 +/- 33.06 gm/m(2)). A set of ECG and non-ECG variables were correlated with LVMI for inclusion in the multiple linear regression model. The model was checked for multicollinearity, normality and homogeneity of variances. Results: The final regression equation formulated with the help of unstandardized coefficients and constant was LVMI=18.494+ 1.704 (aLL) + 0.969 (RaVL+SV3) + 0.295 (MBP) + 15.406 (IHD) (aLL - sum of deflections in augmented limb leads; RaVL+SV3 - sum of deflection of (R wave in aVL + S wave in V3); MBP - mean blood pressure; IHD=1 for the presence of the disease, IHD=0 for the absence of the disease). Conclusion: In the model, 50.4% of the variability in LV mass is explained by the variables used. The findings warrant further studies for the development of better and validated models that can be incorporated in microprocessor-based ECG devices. The determination of LVMI with ECG only will be a cost-effective and readily accessible tool in patient care.
引用
收藏
页码:163 / 172
页数:10
相关论文
共 50 条
  • [21] LEFT-VENTRICULAR FUNCTION AND REGRESSION OF LEFT-VENTRICULAR HYPERTROPHY IN ESSENTIAL-HYPERTENSION
    CLEMENT, DL
    DEBUYZERE, M
    DUPREZ, D
    AMERICAN JOURNAL OF HYPERTENSION, 1993, 6 (03) : S14 - S19
  • [22] A prediction model for left ventricular mass in patients at high cardiovascular risk
    Meijs, Matthijs F. L.
    Vergouwe, Yvonne
    Cramer, Maarten J. M.
    Vonken, Evert-Jan A.
    Velthuis, Birgitta K.
    Verton, David J.
    van der Graaf, Yolanda
    Visseren, Frank L.
    Mali, Willem P.
    Doevendans, Pieter A.
    Bots, Michiel L.
    EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION, 2010, 17 (06): : 621 - 627
  • [23] Risk assessment of echocardiographic left ventricular hypertrophy with electrocardiography, body mass index and blood pressure
    Varis, Juha P.
    Puukka, Pauli J.
    Karanko, Hannu M.
    Jula, Antti M.
    BLOOD PRESSURE, 2014, 23 (01) : 39 - 46
  • [24] Risk factors associated with increased left ventricular mass index in chronic kidney disease patients evaluated using echocardiography
    Matsumoto, Mayumi
    Io, Hiroaki
    Furukawa, Masako
    Okumura, Kozue
    Masuda, Atsumi
    Seto, Takuya
    Takagi, Miyuki
    Sato, Michiko
    Nagahama, Lili
    Omote, Keisuke
    Hisada, Atsuko
    Horikoshi, Satoshi
    Tomino, Yasuhiko
    JOURNAL OF NEPHROLOGY, 2012, 25 (05) : 794 - 801
  • [25] Reduction of left ventricular mass by antihypertensive treatment does not improve exercise performance in essential hypertension
    Fagard, RH
    Lijnen, PJ
    JOURNAL OF HYPERTENSION, 1997, 15 (03) : 309 - 317
  • [26] Different effects of temocapril and cadralazine on electrocardiographic voltages and left ventricular mass in patients with essential hypertension
    Tomita, S
    Takata, M
    Yasumoto, K
    Tomoda, F
    Ueno, H
    Inoue, H
    JAPANESE HEART JOURNAL, 1999, 40 (01): : 55 - 63
  • [27] Association of increased plasma cardiotrophin-1 with inappropriate left ventricular mass in essential hypertension
    Lopez, Begona
    Castellano, Jose M.
    Gonzalez, Arantxa
    Barba, Joaquin
    Diez, Javier
    HYPERTENSION, 2007, 50 (05) : 977 - 983
  • [28] Association Between AGT M235T and Left Ventricular Mass in Vietnamese Patients Diagnosed With Essential Hypertension
    Tran, Tuan Thanh
    Mai, Thao Phuong
    Tran, Ha Chau Bich
    Le, Linh Hoang Gia
    Vu, Hoang Anh
    Tran, Trang Kim
    Hoang, Sy Van
    Chau, Hoa Ngoc
    Do, Minh Duc
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2021, 8
  • [29] Left ventricular mass change during treatment and outcome in patients with essential hypertension
    Koren, MJ
    Ulin, RJ
    Koren, AT
    Laragh, JH
    Devereux, RB
    AMERICAN JOURNAL OF HYPERTENSION, 2002, 15 (12) : 1021 - 1028
  • [30] Effect of Telmisartan on the Regression of the Left Ventricular Hypertrophy in the Patients of Essential Hypertension
    Misra, Kumar Haraprasad
    Das, Mangala Charana
    Ramani, Y. Roja
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2013, 7 (07) : 1352 - 1355